[PubMed ID: 21194578]
The first GLP-1 drug ever made
Additionally, we utilized various algorithms including reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and multi-item gamma Poisson shrinker (MGPS) to analyze data from the Food and Drug Administrations Adverse Event Reporting System (FAERS) regarding suspected adverse events of AP linked to GLP-1 RAs from January 2005 to September 2023
Ask your clinician: Bring sources, not screenshots
If one injection site keeps becoming sore, it is probably worth switching locations the following week
Limitations of this study include its short 6-week duration, the reliance on self-reported sleep dissatisfaction for recruitment, potential practice effects as both groups showed improvement, and the use of one-tailed significance testing, which can increase the risk of false-positive results